cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Nurix Therapeutics Inc
5 own
4 watching
Current Price
$14.43
$0.35
(2.49%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
755.3M
52-Week High
52-Week High
18.12000
52-Week Low
52-Week Low
4.22000
Average Volume
Average Volume
0.21M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization755.3M
icon52-Week High18.12000
icon52-Week Low4.22000
iconAverage Volume0.21M
iconDividend Yield--
iconP/E Ratio--
What does the Nurix Therapeutics Inc do?
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton s tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; and DeTIL-0255 that is in the Phase 1 clinical trial for the treatment of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The company has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. The company was incorporated in 2009 and is headquartered in San Francisco, California.
Read More
How much money does Nurix Therapeutics Inc make?
News & Events about Nurix Therapeutics Inc.
TipRanks Financial Blog
10 months ago
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nurix Therapeutics (NRIX Research Report), MoonL... Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nurix Therapeutics (NRIX Research Report), MoonLake ...
Zolmax
1 year ago
Nurix Therapeutics, Inc. (NASDAQ:NRIX Get Rating) has been assigned a consensus rating of Moderate Buy from the twelve brokerages that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and ten have assigned a buy ...
Benzinga
1 year ago
Latest Ratings for NRIX DateFirmActionFromTo Feb 2022Wells FargoInitiates Coverage OnEqual-Weight Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Oct 2021SVB LeerinkMaintainsOutperform View More Analyst Ratings for NRIX View the Latest Analyst Ratings read more...
Benzinga
1 year ago
Latest Ratings for NRIX DateFirmActionFromTo Feb 2022Wells FargoInitiates Coverage OnEqual-Weight Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Oct 2021SVB LeerinkMaintainsOutperform View More Analyst Ratings for NRIX View the Latest Analyst Ratings read more...
Globe Newswire
1 year ago
-- IRAK4 Program Represents the First of Up to Five Degrader Programs Within the 2019 Discovery Collaboration Agreement -- -- Nurix to Receive a $20 Million Option Fee -- FOSTER CITY, Calif. and SAN FRANCISCO, March 20, 2023 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) and Nurix ...
Frequently Asked Questions
Frequently Asked Questions
What is Nurix Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Nurix Therapeutics Inc shares?
plus_minus_icon
How can I buy Nurix Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Nurix Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Nurix Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Nurix Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Nurix Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Nurix Therapeutics Inc?
plus_minus_icon
What percentage is Nurix Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Nurix Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$14.43
$0.35
(2.49%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
CABALETTA BIO INC
CABALETTA BIO INC
$13.96
$-1.19 (-7.85 %)
ARCUTIS BIOTHERAPEUTICS INC
ARCUTIS BIOTHERAPEUTICS INC
$9.45
$-0.80 (-7.80 %)
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
$24.52
$2.70 (12.37 %)
89bio Inc
89bio Inc
$8.89
$-0.27 (-2.95 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
CABALETTA BIO INC
CABALETTA BIO INC
$13.96
$-1.19 (-7.85 %)
ARCUTIS BIOTHERAPEUTICS INC
ARCUTIS BIOTHERAPEUTICS INC
$9.45
$-0.80 (-7.80 %)
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
$24.52
$2.70 (12.37 %)
89bio Inc
89bio Inc
$8.89
$-0.27 (-2.95 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00